Latest Articles about RIGL

Narrower-Than-Expected Loss at Rigel Pharma - Analyst Blog

Zacks Equity Research — Thu, 09 May 2013 18:00:01 Z

Rigel Pharmaceuticals ' ( RIGL ) first-quarter 2013 loss of 29 cents per share was narrower than both the Zacks Consensus Estimate as well as the year-ago quarter loss of 32 cents. The

AZN Reports Data on Fostamatinib - Analyst Blog

Zacks Equity Research — Tue, 09 Apr 2013 03:08:59 Z

AstraZeneca ( AZN ) announced top-line data from the phase III study (OSKIRA-1: n = 923) on its rheumatoid arthritis (RA) candidate fostamatinib. The study assessed the safety and efficacy

Mid-Morning Market Update: Markets Tumble, F5 Networks Cuts View

Jake L'Ecuyer — Fri, 05 Apr 2013 18:12:43 Z

Following the market opening Friday, the Dow traded down 0.89 percent to 14,475.45 while the NASDAQ dropped 1.40 percent to 3,179.67. The S&P also fell, declining 1.08 percent to

Pre-Market Most Active for Apr 5, 2013 : BAC, RIGL, QQQ, CSCO, MT, FB, SIRI, INTC, NOK, RDS/A, BDN, STO

NASDAQ.com News — Fri, 05 Apr 2013 16:39:58 Z

The NASDAQ 100 Pre-Market Indicator is down -20.23 to 2,774.69. The total Pre-Market volume is currently 7,166,894 shares traded. The following are the most active stocks for the

Loss at Rigel Narrower Than Expected - Analyst Blog

Zacks Equity Research — Wed, 06 Mar 2013 23:18:01 Z

Rigel Pharmaceuticals ' ( RIGL ) fourth quarter 2012 loss of 30 cents per share was narrower than the Zacks Consensus Estimate of a loss of 32 cents and the year-ago loss of 36 cents. The

Company News for March 06, 2013 - Corporate Summary

Zacks Equity Research — Wed, 06 Mar 2013 19:36:01 Z

• Shares of QUALCOMM, Inc. (NASDAQ: QCOM ) surged 2% on Tuesday after the company announced that it has raised its dividend from 25 cents to 35 cents. Moreover, it also

Pre-Market Earnings Report for March 5, 2013 : BNS, QUAD, HEES, RIGL, MEMP, CKP, CVGW, MCGC, BKR

NASDAQ.com News — Tue, 05 Mar 2013 02:00:04 Z

The following companies are expected to report earnings prior to market open on 03/05/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Bank of Nova Scotia (

Call strategy wagers on Rigel rebound

David Russell — Tue, 19 Feb 2013 20:55:22 Z

One investor apparently thinks that Rigel Pharmaceuticals is ready to bounce after a major drop last year. optionMONSTER's Heat Seeker monitoring program detected the purchase of 2,010 June 10

Mid-Afternoon Market Update: SolarCity Hangs on to Gains, Rigel Pharma Continues to Hurt

Benzinga — Fri, 14 Dec 2012 01:35:03 Z

Toward the end of trading Thursday, the Dow traded down 0.71 percent to 13,151.63 while the NASDAQ fell 0.97 percent to 2,984.68. The S&P also fell, decreasing 0.81 percent to 1,416.98.

Mid-Day Market Update: Markets Go Red, SolarCity IPO a Success

Benzinga — Thu, 13 Dec 2012 23:54:44 Z

Mid-way through trading Thursday, the Dow traded down 0.38 percent to 13,194.63 while the NASDAQ fell 0.67 percent to 2,993.63. The S&P also fell, decreasing 0.55 percent to 1,420.69.

Mid-Morning Market Update: Markets Cautiously Rising, Best Buy Boosts

Benzinga — Thu, 13 Dec 2012 20:59:47 Z

Following the market opening Thursday, the Dow traded up 0.01 percent to 13,247.25 while the NASDAQ rose 0.29 percent to 3,022.44. The S&P also rose, increasing 0.07 percent to

Pre-Market Most Active for Dec 13, 2012 : CLWR, NOK, BBY, BAC, ERIC, WMB, ACMP, S, RFMD, RIMM, AAPL, RIGL

NASDAQ.com News — Thu, 13 Dec 2012 18:39:59 Z

The NASDAQ 100 Pre-Market Indicator is down -1.47 to 2,673.1. The total Pre-Market volume is currently 23,289,294 shares traded. The following are the most active stocks for the pre-market

Pre-Market Most Active for Oct 3, 2012 : WLP, PCS, SRPT, QQQ, BAC, NOK, S, VOD, BBY, RIGL, RIMM, SIRI

NASDAQ.com News — Wed, 03 Oct 2012 16:39:54 Z

The NASDAQ 100 Pre-Market Indicator is up 2.88 to 2,802.17. The total Pre-Market volume is currently 5,638,131 shares traded. The following are the most active stocks for the pre-market

AstraZeneca, RIGL in Licensing Deal - Analyst Blog

Zacks Equity Research — Thu, 21 Jun 2012 01:54:00 Z

AstraZeneca ( AZN ) and Rigel Pharmaceuticals, Inc. ( RIGL ) recently announced that they have entered into a licensing agreement for Rigel's asthma candidate, R256. Per the terms of the

3 Nasdaq Stocks for Active Investors

David Penn — Thu, 08 Mar 2012 03:23:01 Z

Today's look at stocks pulling back above the 200-day moving average includes a pair of biotechnology stocks, known for their volatility and ability to make big moves, and an Internet